Siemens announced FDA has cleared features associated with their new Biograph mCT positron emission tomography/computed tomography scanner, which the company unveiled at RSNA in November 2011.
Siemens Healthcare announced FDA has cleared features associated with their new Biograph mCT positron emission tomography/computed tomography scanner, which the company unveiled at the RSNA meeting in November 2011.
The Biograph mCT provides precise measurement of metabolic processes and data qualification, as well as cardiac blood flow. The PET quantification allows physician to more precisely characterize cancer lesions, and the ability to measure myocardial blood flow allows for more accurate assessment of multi-vessel disease, the company said. In neurology, noninvasive assessment of the brain can potentially improve the diagnosis and management of patients who present with signs of dementia, according to the company.
The Biograph mCT incorporates Siemens’ OptisoHD (High Definition) detector system, which features a fine volumetric resolution of 87 mm. Also included is Time of Flight (TOF) and HD-PET, ensuring fast, precise images with minimum radiation dose, according to Siemens. The Quanti-QC daily system normalization can be performed overnight, calibrating and tuning the system to the right specifications.
The system also features a patient handling system to address differential deflection, the Auto Cardiac Registration that automatically aligns CT and PET heart images and reduces variability between users, as well as Siemens Molecular and Anatomical Registration Technologies, which the company said was a new form of attenuation correction for neurological images that doesn’t require CT data.
The Biograph mCT is expected to ship in May 2012.
European Society of Breast Imaging Issues Updated Breast Cancer Screening Recommendations
April 24th 2024One of the recommendations from the European Society of Breast Imaging (EUSOBI) is annual breast MRI exams starting at 25 years of age for women deemed to be at high risk for breast cancer.
Study Reveals Benefits of Photon-Counting CT for Assessing Acute Pulmonary Embolism
April 23rd 2024In comparison to energy-integrating detector CT for the workup of suspected acute pulmonary embolism, the use of photon-counting detector CT reduced radiation dosing by 48 percent, according to newly published research.
Could a Newly FDA-Cleared C-Arm Device Bolster Efficiency for Interventional Radiologists?
April 22nd 2024In addition to advanced imaging quality and dose efficiency, the Philips Zenition 30 mobile C-arm device emphasizes personalized user profiles and automated customization to help reduce procedure time.